Biopharmaceutical company focused on HIV prevention and treatment
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2024 | DGA GROUP GOVERNMENT RELATIONS LLC |
2nd Quarter (Apr 1 - June 30) Registration |
— |
| Firm | Filings | Expenses |
|---|---|---|
| DGA GROUP GOVERNMENT RELATIONS LLC | 8 | — |
| Issue | Activities |
|---|---|
| Trade (domestic/foreign) | 7 |